Nyra Medical Heart Valve Regurgitation Implant Delivery System
Summary
USPTO published patent application US20260108354A1 for Nyra Medical Inc.'s implant delivery system designed to reduce heart valve regurgitation. The application was filed on December 22, 2025, with inventor Sai Muralidhar PADALA. The system comprises an implant catheter within a guide catheter containing hypotubes for braided tethers, with an implant holder configured to receive an implant disposable around a heart valve leaflet to improve coaptation.
“The implant configured to be disposed around a portion of a leaflet of a heart valve to improve coaptation of the heart valve.”
About this source
GovPing monitors USPTO Patent Applications - Prosthetics (A61F) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 222 changes logged to date.
What changed
USPTO published Nyra Medical Inc.'s patent application (US20260108354A1) covering an implant delivery system for reducing heart valve regurgitation. The abstract describes an implant catheter disposed within a guide catheter inner lumen, with hypotubes receiving braided tethers and an implant holder configured to dispose around a heart valve leaflet to improve coaptation. Competitors in the cardiac implant or transcatheter valve space may wish to review this filing for potential freedom-to-operate implications.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
SYSTEMS, DEVICES, AND METHODS FOR REDUCING HEART VALVE REGURGITATION
Application US20260108354A1 Kind: A1 Apr 23, 2026
Assignee
Nyra Medical, Inc.
Inventors
Sai Muralidhar PADALA
Abstract
Embodiments described herein relate to an implant delivery system for delivering an implant for reducing heart valve regurgitation. The implant delivery system may include an implant catheter disposed in an inner lumen of a guide catheter. The implant catheter may include one or more hypotubes disposed therein, each hypotube configured to receive an elongate member such as a braided tether. A distal end of the implant catheter may be coupled to an implant holder configured to receive the implant. The implant holder may define one or more channels, each channel configured to receive a portion of a respective elongate member. The elongate members configured to couple the implant to the implant holder and transition the implant between configurations. The implant configured to be disposed around a portion of a leaflet of a heart valve to improve coaptation of the heart valve.
CPC Classifications
A61F 2/2466 A61F 2/2418 A61B 2017/00243
Filing Date
2025-12-22
Application No.
19429313
Mentioned entities
Parties
Related changes
Get daily alerts for USPTO Patent Applications - Prosthetics (A61F)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Prosthetics (A61F) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.